207 related articles for article (PubMed ID: 36416308)
1. Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis.
Dang X; Zhang L; Franco A; Dorn Ii GW
Hum Mol Genet; 2023 Mar; 32(7):1208-1222. PubMed ID: 36416308
[TBL] [Abstract][Full Text] [Related]
2. ALS-associated mutation SOD1
Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
[TBL] [Abstract][Full Text] [Related]
3. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.
Luo G; Yi J; Ma C; Xiao Y; Yi F; Yu T; Zhou J
PLoS One; 2013; 8(12):e82112. PubMed ID: 24324755
[TBL] [Abstract][Full Text] [Related]
4. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
5. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
[TBL] [Abstract][Full Text] [Related]
6. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.
Song W; Song Y; Kincaid B; Bossy B; Bossy-Wetzel E
Neurobiol Dis; 2013 Mar; 51():72-81. PubMed ID: 22819776
[TBL] [Abstract][Full Text] [Related]
7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
8. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
10. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis.
Miquel E; Cassina A; Martínez-Palma L; Bolatto C; Trías E; Gandelman M; Radi R; Barbeito L; Cassina P
PLoS One; 2012; 7(4):e34776. PubMed ID: 22509356
[TBL] [Abstract][Full Text] [Related]
11. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Ringer C; Büning LS; Schäfer MK; Eiden LE; Weihe E; Schütz B
Neurobiol Dis; 2013 Jun; 54():32-42. PubMed ID: 23466699
[TBL] [Abstract][Full Text] [Related]
12. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
13. REEP1 Preserves Motor Function in SOD1
Qin S; You P; Yu H; Su B
Neurosci Bull; 2023 Jun; 39(6):929-946. PubMed ID: 36520405
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels.
Moller A; Bauer CS; Cohen RN; Webster CP; De Vos KJ
Hum Mol Genet; 2017 Dec; 26(23):4668-4679. PubMed ID: 28973175
[TBL] [Abstract][Full Text] [Related]
15. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
16. Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1.
Nemtsova Y; Steinert BL; Wharton KA
Mol Cell Neurosci; 2023 Jun; 125():103834. PubMed ID: 36868541
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of ALCAT1 mitigates amyotrophic lateral sclerosis by attenuating SOD1 protein aggregation.
Liu X; Zhang J; Li J; Song C; Shi Y
Mol Metab; 2022 Sep; 63():101536. PubMed ID: 35772643
[TBL] [Abstract][Full Text] [Related]
18. Progressive Mitochondrial SOD1
Méndez-López I; Sancho-Bielsa FJ; Engel T; García AG; Padín JF
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360957
[TBL] [Abstract][Full Text] [Related]
19. Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1
Hernández S; Salvany S; Casanovas A; Piedrafita L; Soto-Bernardini MC; Tarabal O; Blasco A; Gras S; Gatius A; Schwab MH; Calderó J; Esquerda JE
Neurotherapeutics; 2023 Oct; 20(6):1820-1834. PubMed ID: 37733208
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons.
Magrané J; Sahawneh MA; Przedborski S; Estévez ÁG; Manfredi G
J Neurosci; 2012 Jan; 32(1):229-42. PubMed ID: 22219285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
